Results 191 to 200 of about 28,620 (235)

Assessment of Pharmacokinetic Interaction and Clinical Efficacy of Clopidogrel Co-administered with Ilaprazole. [PDF]

Clin Pharmacol Drug Dev
N D, A P, T M V, N A R.
europepmc   +1 more source

Cost-Effectiveness of Pharmacogenomics-Guided Treatment in Cardiovascular Disease: An Umbrella Review. [PDF]

Pharmgenomics Pers Med
Janković SM, Milosavljević M, Stević I, Ašić A, Jusić A, Devaux Y, Belančić A, Bektay MY, Pejčić AV.   +8 more
europepmc   +1 more source

Distribution of <i>CYP2C19</i> genetic polymorphisms and pharmacogenomic implications in 11,710 patients with cardiovascular and cerebrovascular conditions: a large population-based study in eastern China. [PDF]

Front Genet
Peng M, He M, Chen Y, Zhu X, Li J.
europepmc   +1 more source

VALID regimen of voriconazole optimizes therapeutic target attainment and minimizes adverse events in patients with liver dysfunction. [PDF]

Front Pharmacol
Li J, Zhao Y, Liu H, Zhang Y, Ma J, Jiang Y, Zhao J, Zhang B, Yan M.   +8 more
europepmc   +1 more source

Repeated voriconazole therapeutic drug monitoring in hospitalised patients: a real-world cohort study of out-of-range exposure and concentration response to dose adjustment. [PDF]

Front Pharmacol
He T, Liu Z, Liang L, Qiao W, Chen S, Liu J, Liu M, Li W.   +7 more
europepmc   +1 more source

Pharmacogenetic phenoconversion modeling of drug–drug–gene interactions on CYP2C19 activity: effects of comedication by genotype on escitalopram concentrations

Stingl J, Molden E, Hole K, Wollmann BM, Viviani R.   +4 more
europepmc   +1 more source

Pharmacogenetics of CYP2C19: Functional and Clinical Implications of a New Variant CYP2C19*17 [PDF]

British Journal of Clinical Pharmacology, 2010
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • CYP2C19 polymorphisms may have clinical consequences in relation to drugs extensively metabolized by the enzyme.• Recently a new variant CYP2C19*17 was discovered.• Unlike other commonly studied variant alleles, notably CYP2C19*2 and CYP2C19*3, which are defective, CYP2C19*17 is associated with enhanced ...
Thierry Girard
exaly   +5 more sources